Literature DB >> 1931626

Breast cancer screening as public health policy in Finland.

M Hakama1, L Elovainio, R Kajantie, K Louhivuori.   

Abstract

A nationwide mammographic screening for breast cancer was started in Finland in 1987. During the first 2 years of the organised screening programme, 126,000 women were invited. Most of them (103,000) belonged to the birth year cohort in the 50-59 years' age groups. Among the 112,000 screenees, 418 cancers (0.4%) were found. Specificity of the test was about 96%. The screening prevalence was 2.4 times the annual incidence and a minimum estimate for the detection rate among those invited was 1.6 times that among those not invited. These estimates indicate a relatively low test and programme sensitivity. The final effectiveness of a public health policy cannot be predicted on the basis of limited preventive trials, and there is need to evaluate also a public health policy by experimental means.

Entities:  

Mesh:

Year:  1991        PMID: 1931626      PMCID: PMC1977451          DOI: 10.1038/bjc.1991.436

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

2.  [Mammographic screening confirmation of breast cancer biological characteristics--a flow cytometric study].

Authors:  O P Kallioniemi; A Kärkkäinen; J Mattila; O Auvinen; T Koivula; M Hakama
Journal:  Duodecim       Date:  1989

3.  Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.

Authors:  A L Verbeek; J H Hendriks; R Holland; M Mravunac; F Sturmans; N E Day
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

4.  Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study.

Authors:  H J Collette; N E Day; J J Rombach; F de Waard
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

5.  Rapid alkalinisation for flavone acetic acid administration: a potentially hazardous procedure.

Authors:  J Verweij; G Stoter; P Dodion; M Farinean
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

6.  DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential.

Authors:  O P Kallioniemi; A Kärkkäinen; O Auvinen; J Mattila; T Koivula; M Hakama
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

7.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

8.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

9.  Evaluation of screening programmes for gynaecological cancer.

Authors:  M Hakama; J Chamberlain; N E Day; A B Miller; P C Prorok
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

  9 in total
  5 in total

1.  Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.

Authors:  Tron A Moger; Gudrun M W Bjørnelv; Eline Aas
Journal:  Eur J Health Econ       Date:  2015-08-04

2.  Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.

Authors:  A Auvinen; T Tammela; U H Stenman; I Uusi-Erkkilä; J Leinonen; F H Schröder; M Hakama
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

3.  European randomized study of prostate cancer screening: first-year results of the Finnish trial.

Authors:  L Määttänen; A Auvinen; U H Stenman; S Rannikko; T Tammela; J Aro; H Juusela; M Hakama
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

4.  Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients.

Authors:  J Anttinen; H Kautiainen; T Kuopio
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

5.  Special features of health services and register based trials - experiences from a randomized trial of childbirth classes.

Authors:  Elina Hemminki; Kaija Heikkilä; Tiina Sevón; Päivikki Koponen
Journal:  BMC Health Serv Res       Date:  2008-06-11       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.